{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:00:21Z","timestamp":1790542821385,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,23]]},"DOI":"10.7759\/cureus.28317","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:19:26Z","timestamp":1661300366000},"source":"Crossref","is-referenced-by-count":17,"title":["Colistin Resistance Among Multi-Drug Resistant Gram-Negative Bacterial Isolates From Different Clinical Samples of ICU Patients: Prevalence and Clinical Outcomes"],"prefix":"10.7759","author":[{"given":"Kumudini","family":"Panigrahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basanti K","family":"Pathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranita","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhransu","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok  K","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught LA","year":"2016","unstructured":"van Vught LA, Klein Klouwenberg PM, Spitoni C, et al.. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016, 315:1469-79. 10.1001\/jama.2016.2691","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent JL","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, et al.. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009, 302:2323-9. 10.1001\/jama.2009.1754","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks460","article-title":"Confronting the threat of multidrug-resistant gram-negative bacteria in critically ill patients","volume":"68","author":"Cohen J","year":"2013","unstructured":"Cohen J. Confronting the threat of multidrug-resistant gram-negative bacteria in critically ill patients. J Antimicrob Chemother. 2013, 68:490-1. 10.1093\/jac\/dks460","journal-title":"J Antimicrob Chemother"},{"key":"ref4","unstructured":"Countries should reduce use of colistin in animals to decrease the risk of antimicrobial resistance. (2016). Accessed. November 8, 2020: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2016\/07\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas ME","year":"2005","unstructured":"Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005, 40:1333-41. 10.1086\/429323","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw274","article-title":"Transferable resistance to colistin: a new but old threat","volume":"71","author":"Schwarz S","year":"2016","unstructured":"Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother. 2016, 71:2066-70. 10.1093\/jac\/dkw274","journal-title":"J Antimicrob Chemother"},{"key":"ref7","article-title":"Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India","volume":"58","author":"Wattal C","year":"2010","unstructured":"Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India. 2010, 58:32-36.","journal-title":"J Assoc Physicians India"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan AO","year":"2014","unstructured":"Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014, 5:643. 10.3389\/fmicb.2014.00643","journal-title":"Front Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01351.x","article-title":"Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)","volume":"12","author":"Gales AC","year":"2006","unstructured":"Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect. 2006, 12:315-21. 10.1111\/j.1469-0691.2005.01351.x","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.10.002","article-title":"Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli","volume":"25","author":"Sader HS","year":"2005","unstructured":"Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents. 2005, 25:95-109. 10.1016\/j.ijantimicag.2004.10.002","journal-title":"Int J Antimicrob Agents"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01267-16","article-title":"Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY antimicrobial surveillance program","volume":"60","author":"Castanheira M","year":"2016","unstructured":"Castanheira M, Griffin MA, Deshpande LM, Mendes RE, Jones RN, Flamm RK. Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2016, 60:5623-4. 10.1128\/AAC.01267-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01870-15","article-title":"Correlation of \u03b2-Lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program","volume":"60","author":"Bradford PA","year":"2015","unstructured":"Bradford PA, Kazmierczak KM, Biedenbach DJ, Wise MG, Hackel M, Sahm DF. Correlation of \u03b2-Lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program. Antimicrob Agents Chemother. 2015, 60:1385-92. 10.1128\/AAC.01870-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0B013E3181652FAE","article-title":"Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study","volume":"36","author":"Matthaiou DK","year":"2008","unstructured":"Matthaiou DK, Michalopoulos A, Rafailidis PI, et al.. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med. 2008, 36:807-11. 10.1097\/CCM.0B013E3181652FAE","journal-title":"Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03649.x","article-title":"Colonization and infection by colistin-resistant gram-negative bacteria in a cohort of critically ill patients","volume":"17","author":"Kontopidou F","year":"2011","unstructured":"Kontopidou F, Plachouras D, Papadomichelakis E, et al.. Colonization and infection by colistin-resistant gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect. 2011, 17:E9-E11. 10.1111\/j.1469-0691.2011.03649.x","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.13.30183","article-title":"Detection of mcr-1 colistin resistance gene in polyclonal Escherichia coli isolates in Barcelona, Spain, 2012 to 2015","volume":"21","author":"Prim N","year":"2016","unstructured":"Prim N, Rivera A, Rodr\u00edguez-Navarro J, Espa\u00f1ol M, Turbau M, Coll P, Mirelis B. Detection of mcr-1 colistin resistance gene in polyclonal Escherichia coli isolates in Barcelona, Spain, 2012 to 2015. Euro Surveill. 2016, 21:10.2807\/1560-7917.ES.2016.21.13.30183","journal-title":"Euro Surveill"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30527-8","article-title":"Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study","volume":"299","author":"Wang Y","year":"2017","unstructured":"Wang Y, Tian GB, Zhang R, et al.. Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. Lancet Infect Dis. 2017, 299:30527-8. 10.1016\/S1473-3099(16)30527-8","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30528-X","article-title":"Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study","volume":"4","author":"Quan J","year":"2017","unstructured":"Quan J, Li X, Chen Y, et al.. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect Dis. 2017, 4:400-410. 10.1016\/S1473-3099(16)30528-X","journal-title":"Lancet Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.27.30280","article-title":"Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016","volume":"21","author":"Xavier BB","year":"2016","unstructured":"Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, Malhotra-Kumar S. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016, 21:30280. 10.2807\/1560-7917.ES.2016.21.27.30280","journal-title":"Euro Surveill"},{"key":"ref19","unstructured":"European Centre for Disease Prevention and Control. antimicrobial resistance surveillance in Europe 2013. (2014). Accessed: February 2, 2020: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/antimicrobial-resistance-surveillance europe-2013.pdf (2014)."},{"key":"ref20","unstructured":"Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSIEUCAST Polymyxin Breakpoints Working Group. (2016). Accessed. January 22, 2019: http:\/\/http\/\/www.eucast.org."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4065603","article-title":"Multidrug resistant and extensively drug resistant bacteria: a study","volume":"2016","author":"Basak S","year":"2016","unstructured":"Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathog. 2016, 2016:4065603. 10.1155\/2016\/4065603","journal-title":"J Pathog"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu YY","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, et al.. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016, 16:161-68. 10.1016\/S1473-3099(15)00424-7","journal-title":"Lancet Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-019-0339-4","article-title":"Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients","volume":"18","author":"Zafer MM","year":"2019","unstructured":"Zafer MM, El-Mahallawy HA, Abdulhak A, Amin MA, Al-Agamy MH, Radwan HH. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann Clin Microbiol Antimicrob. 2019, 18:40. 10.1186\/s12941-019-0339-4","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.11.009","article-title":"Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance","volume":"47","author":"Olaitan AO","year":"2016","unstructured":"Olaitan AO, Morand S, Rolain JM. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance. Int J Antimicrob Agents. 2016, 47:1-3. 10.1016\/j.ijantimicag.2015.11.009","journal-title":"Int J Antimicrob Agents"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe JR","year":"2007","unstructured":"Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2007, 51:3726-30. 10.1128\/AAC.01406-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw260","article-title":"Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex","volume":"71","author":"Gu\u00e9rin F","year":"2016","unstructured":"Gu\u00e9rin F, Isnard C, Sinel C, Morand P, Dhalluin A, Cattoir V, Giard JC. Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex. J Antimicrob Chemother. 2016, 71:3058-61. 10.1093\/jac\/dkw260","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091444","article-title":"Colistin heteroresistance in klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations","volume":"8","author":"Cheong HS","year":"2019","unstructured":"Cheong HS, Kim SY, Wi YM, Peck KR, Ko KS. Colistin heteroresistance in klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations. J Clin Med. 2019, 8:1444. 10.3390\/jcm8091444","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02432-14","article-title":"Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme","volume":"58","author":"Napier BA","year":"2014","unstructured":"Napier BA, Band V, Burd EM, Weiss DS. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob Agents Chemother. 2014, 58:5594-7. 10.1128\/AAC.02432-14","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97516-colistin-resistance-among-multi-drug-resistant-gram-negative-bacterial-isolates-from-different-clinical-samples-of-icu-patients-prevalence-and-clinical-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:49Z","timestamp":1707508189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97516-colistin-resistance-among-multi-drug-resistant-gram-negative-bacterial-isolates-from-different-clinical-samples-of-icu-patients-prevalence-and-clinical-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.28317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,23]]}}}